Suchergebnisse - "antibodies"

PubPharm (713.139)

21

Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination

enthalten in: Vaccine | 2024

von Chong, C. | Kam, K. | Zhang, J. | +8

22

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults

enthalten in: Vaccine | 2024

von Cummings, J. | Polhemus, M. | Kester, K. | +13

23

Benralizumab noninferior to mepolizumab for EGPA

enthalten in: Nature reviews. Rheumatology | 2024

von Onuora, S.

24

Heritability and genome-wide association study of vaccine-induced immune response in Beagles : A pilot study

enthalten in: Vaccine | 2024

von Blake, J. | Thompson, J. | HogenEsch, H. | +1

25

Report of the 2022 Banff Heart Concurrent : Focus on non-human leukocyte antigen antibodies in rejection and the pathology of "mixed" rejection

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2024

von Fedrigo, M. | Berry, G. | Coutance, G. | +12

26

Harnessing metabolic plasticity in CHO cells for enhanced perfusion cultivation

enthalten in: Biotechnology and bioengineering | 2024

von Nöbel, M. | Barry, C. | MacDonald, M. | +7

27

Targeted immunotherapy to cancer stem cells : A novel strategy of anticancer immunotherapy

enthalten in: Critical reviews in oncology/hematology | 2024

von Yi, S. | Wei, M. | Zhao, L.

28

Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia

enthalten in: Leukemia research | 2024

von Bourne, G. | Diebold, K. | Espinoza-Gutarra, M. | +6

29

Dual blockade of interleukin-17A and interleukin-17F as a therapeutic strategy for liver fibrosis : Investigating the potential effect and mechanism of brodalumab

enthalten in: Cytokine | 2024

von Matsuda, K. | Kotani, H. | Hisamoto, T. | +5

30

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60) : a randomised, non-comparative, phase 2 study

enthalten in: The Lancet. Oncology | 2024

von Kim, S. | Ghiringhelli, F. | de la Fouchardière, C. | +25